04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
On February 27th, the Federal Trade Commission (FTC) and the Attorney General of the Commonwealth of...
Read More >
In Velox Express, Inc., 368 NLRB No. 61 (2019), the National Labor Relations Board ruled that miscla...
Read More >
Organisations that appreciate how working parents have to balance their work and home responsibiliti...
Read More >
In early February, Senator Amy Klobuchar, new Chair of the Senate Judiciary Subcommittee on Antitrus...
Read More >
Call Center Company Refused to Accommodate Religious Beliefs and Practices of Employee, Federal Agen...
Read More >
This is the last article in our three-part series focused on the implications of robots and artifici...
Read More >